Volumetric Karl Fischer titration accurately determines water content in various samples, adhering to European Pharmacopoeia ...

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...

The peptide commonly referred to as SNAP-8 (acetyl octapeptide-3) is a synthetic fragment derivative of SNAP-25, engineered ...

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

The executives of the companies say by pairing weight-loss drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) with ...

ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no ...

In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping ...

New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable setback" for those who hoped GLP-1 receptor agonists might slow Alzheimer's ...